Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia
- PMID: 8535876
- PMCID: PMC2528479
- DOI: 10.1136/fn.73.3.f174
Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia
Abstract
The effects of two different doses of magnesium sulphate (MgSO4) were evaluated in a group of 15 full term infants with Apgar scores of < 6 at 10 minutes, studied within 12 hours of delivery. Seven infants received 400 mg/kg MgSO4 and eight received 250 mg/kg. After the larger dose, mean arterial pressure (MAP) fell by a mean of 6 mm Hg (13%) at one hour but was not significantly reduced thereafter. Respiratory depression lasted three to six hours. EEG readings and heart rate were not significantly different. Mean serum Mg2+ increased from 0.79 to 3.6 mmol/l at one hour. After 250 mg/kg MgSO4, MAP, EEG, tone and heart rate were unchanged. One infant developed transient respiratory depression. Mean serum Mg2+ rose from 0.71 to 2.42 mmol/l at one hour. MgSO4 (400 mg/kg) has an unacceptable risk of hypotension; 250 mg/kg MgSO4 was not associated with hypotension although respiratory depression can occur.
Similar articles
-
Magnesium therapy in birth asphyxia.Indian J Pediatr. 2006 Mar;73(3):209-12. doi: 10.1007/BF02825482. Indian J Pediatr. 2006. PMID: 16567913 Clinical Trial.
-
Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial.Pediatrics. 2009 May;123(5):e764-9. doi: 10.1542/peds.2007-3642. Epub 2009 Apr 6. Pediatrics. 2009. PMID: 19349375 Clinical Trial.
-
Short-term outcome of magnesium sulfate infusion in perinatal asphyxia.Mymensingh Med J. 2013 Oct;22(4):727-35. Mymensingh Med J. 2013. PMID: 24292304 Clinical Trial.
-
Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.Clin Pharmacokinet. 2000 Apr;38(4):305-14. doi: 10.2165/00003088-200038040-00002. Clin Pharmacokinet. 2000. PMID: 10803454 Review.
-
Magnesium sulphate replacement therapy in cardiac surgery patients: A systematic review.Aust Crit Care. 2019 Sep;32(5):421-433. doi: 10.1016/j.aucc.2018.09.004. Epub 2018 Nov 27. Aust Crit Care. 2019. PMID: 30501993
Cited by
-
Neuroprotective therapies after perinatal hypoxic-ischemic brain injury.Brain Sci. 2013 Mar 5;3(1):191-214. doi: 10.3390/brainsci3010191. Brain Sci. 2013. PMID: 24961314 Free PMC article.
-
Amplitude integrated EEG 3 and 6 hours after birth in full term neonates with hypoxic-ischaemic encephalopathy.Arch Dis Child Fetal Neonatal Ed. 1999 Jul;81(1):F19-23. doi: 10.1136/fn.81.1.f19. Arch Dis Child Fetal Neonatal Ed. 1999. PMID: 10375357 Free PMC article.
-
New antioxidant drugs for neonatal brain injury.Oxid Med Cell Longev. 2015;2015:108251. doi: 10.1155/2015/108251. Epub 2015 Jan 5. Oxid Med Cell Longev. 2015. PMID: 25685254 Free PMC article. Review.
-
Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep.J Physiol. 2023 May;601(10):1999-2016. doi: 10.1113/JP284381. Epub 2023 Apr 13. J Physiol. 2023. PMID: 36999348 Free PMC article.
-
Increased concentrations of both NMDA receptor co-agonists D-serine and glycine in global ischemia: a potential novel treatment target for perinatal asphyxia.Amino Acids. 2012 Jul;43(1):355-63. doi: 10.1007/s00726-011-1086-9. Epub 2011 Sep 23. Amino Acids. 2012. PMID: 21947661 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources